Brenner, Darren M.

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInfant Health and Development

Cited by 893

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology

Gastrointestinal motility and disordersProbiotics and Fermented Foods

Cited by 362

Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., et al. (2018) · Gastroenterology

Gastrointestinal motility and disordersInfant Health and Development

Cited by 191

Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: Results of two phase 3 randomized clinical trials

Brenner, D. M., Fogel, R., Dorn, S. D., Krause, R., Eng, P., Kirshoff, R., Nguyen, A., Crozier, R. A., Magnus, L., & Griffin, P. H. (2018) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 145

Efficacy and safety of over-the-counter therapies for chronic constipation: An updated systematic review

Rao, S. S. C., & Brenner, D. M. (2021) · American Journal of Gastroenterology

Gastrointestinal motility and disordersPelvic floor disorders treatments

Cited by 97

Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up

Lackner, J. M., Jaccard, J., Radziwon, C. D., Firth, R. S., Gudleski, G. D., Hamilton, F., Katz, L. A., Keefer, L., Krasner, S. S., Ma, C.-X., et al. (2019) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInfant Health and Development

Cited by 61

Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

Brenner, D. M., & Sayuk, G. S. (2020) · Advances in Therapy

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 55

Gender differences in irritable bowel syndrome: the interpersonal connection

Thakur, E. R., Gurtman, M. B., Keefer, L., Brenner, D. M., Lackner, J. M., & Representing the IBS Outcome Study Research Group (2015) · Neurogastroenterology & Motility

Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments

Cited by 21